165 related articles for article (PubMed ID: 16531543)
1. First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.
Salazar M; Barata A; André S; Venâncio J; Francisco I; Cravo M; Nobre-Leitão C
Gut; 2006 Apr; 55(4):585-6. PubMed ID: 16531543
[No Abstract] [Full Text] [Related]
2. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome.
Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442
[TBL] [Abstract][Full Text] [Related]
3. [A case of rectal GIST treated with imatinib mesylate neoadjuvant therapy to preserve the anus].
Sekoguchi S; Okuyama Y; Enoki Y; Kawakami T; Tomie A; Yamada N; Yoriki H; Fukui A; Hattori T; Kamata K; Tomatsuri N; Nakamura H; Sato H; Kimura H; Yoshida N; Shioaki Y; Fujimoto S
Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1751-7. PubMed ID: 19966517
[TBL] [Abstract][Full Text] [Related]
4. Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST.
de Azevedo CR; Paiva TF; Rossi BM; Guimarães GC; de Souza Begnami MD; Oliveira TB; Barros E Silva MJ; Fanelli MF; de Mello CA
Int J Clin Oncol; 2011 Jun; 16(3):279-83. PubMed ID: 20922448
[TBL] [Abstract][Full Text] [Related]
5. The role of neoadjuvant imatinib mesylate therapy in sphincter-preserving procedures for anorectal gastrointestinal stromal tumor.
Wang JP; Wang T; Huang MJ; Wang L; Kang L; Wu XJ
Am J Clin Oncol; 2011 Jun; 34(3):314-6. PubMed ID: 20622646
[TBL] [Abstract][Full Text] [Related]
6. Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach.
Santos Fernandes Gd; Castro Cotti GC; Freitas D; Cutait R; Hoff PM
Clinics (Sao Paulo); 2009; 64(8):819-21. PubMed ID: 19690669
[No Abstract] [Full Text] [Related]
7. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
8. [Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib].
Bouché O; Lagarde S; Guillou PJ; Ramaholimihaso F; Lubrano D; Diébold MD; Delattre JF; Nguyen TD; Cadiot G; Thiéfin G
Gastroenterol Clin Biol; 2006 Apr; 30(4):636-7. PubMed ID: 16733396
[No Abstract] [Full Text] [Related]
9. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor.
Hou YY; Zhou Y; Lu SH; Qi WD; Xu C; Hou J; Tan YS
World J Gastroenterol; 2009 Apr; 15(15):1910-3. PubMed ID: 19370794
[TBL] [Abstract][Full Text] [Related]
10. Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report.
Ciresa M; D'Angelillo RM; Ramella S; Cellini F; Gaudino D; Stimato G; Fiore M; Greco C; Nudo R; Trodella L
Tumori; 2009; 95(2):236-9. PubMed ID: 19579872
[TBL] [Abstract][Full Text] [Related]
11. Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.
Hamada M; Ozaki K; Horimi T; Tsuji A; Nasu Y; Iwata J; Nagata Y
Int J Clin Oncol; 2008 Aug; 13(4):355-60. PubMed ID: 18704638
[TBL] [Abstract][Full Text] [Related]
12. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour.
Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S
Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362
[TBL] [Abstract][Full Text] [Related]
13. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
Lai IR; Hu RH; Chang KJ
Hepatogastroenterology; 2005; 52(63):826-8. PubMed ID: 15966213
[TBL] [Abstract][Full Text] [Related]
14. Emergence of secondary resistance to imatinib in recurrent gastric GIST.
Jayanthi NV
J Gastrointest Surg; 2010 Dec; 14(12):2018-9; author reply 2020. PubMed ID: 20714935
[No Abstract] [Full Text] [Related]
15. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
Turner J; Batus M; Leslie W; Coogan C; Saclarides TJ
Am Surg; 2010 Aug; 76(8):E110-2. PubMed ID: 21513625
[No Abstract] [Full Text] [Related]
16. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
[TBL] [Abstract][Full Text] [Related]
17. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.
Goh BK; Chow PK; Chuah KL; Yap WM; Wong WK
Eur J Surg Oncol; 2006 Nov; 32(9):961-3. PubMed ID: 16842963
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
[No Abstract] [Full Text] [Related]
19. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor.
Shah JN; Sun W; Seethala RR; Livolsi VA; Fry RD; Ginsberg GG
Gastrointest Endosc; 2005 Apr; 61(4):625-7. PubMed ID: 15812427
[No Abstract] [Full Text] [Related]
20. DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour.
Revheim ME; Hole KH; Bruland OS; Haugland HK; Hall KS; Seierstad T
Acta Oncol; 2011 Jan; 50(1):148-50. PubMed ID: 21110775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
